Published in J Biol Chem on March 12, 2010
The chemokine superfamily revisited. Immunity (2012) 2.83
Effects of exogenous ubiquitin in a polytrauma model with blunt chest trauma. Crit Care Med (2012) 1.50
The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. J Biol Chem (2011) 1.23
The ubiquitin-CXCR4 axis plays an important role in acute lung infection-enhanced lung tumor metastasis. Clin Cancer Res (2013) 1.08
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives. Front Immunol (2015) 1.05
The intricate role of CXCR4 in cancer. Adv Cancer Res (2014) 1.04
CXCR4 over-expression and survival in cancer: a system review and meta-analysis. Oncotarget (2015) 1.04
Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem (2011) 0.96
Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. Proc Natl Acad Sci U S A (2015) 0.94
Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis. Front Immunol (2013) 0.94
Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog Neurobiol (2014) 0.94
Carcinoma cells misuse the host tissue damage response to invade the brain. Glia (2013) 0.92
CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin. Cytokine (2013) 0.89
Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation. Proc Natl Acad Sci U S A (2014) 0.88
The Lottia gigantea shell matrix proteome: re-analysis including MaxQuant iBAQ quantitation and phosphoproteome analysis. Proteome Sci (2014) 0.87
Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification. Biochemistry (2013) 0.86
Emerging roles for immunomodulatory functions of free ISG15. J Interferon Cytokine Res (2013) 0.86
Ubiquitin receptor binding and signaling in primary human leukocytes. Commun Integr Biol (2010) 0.86
Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells. Microcirculation (2014) 0.85
Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism. Retrovirology (2013) 0.85
Initial assessment of the role of CXC chemokine receptor 4 after polytrauma. Mol Med (2012) 0.84
Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function. Mol Med (2014) 0.84
Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction. Curr Top Med Chem (2012) 0.82
Targeted delivery of ubiquitin-conjugated BH3 peptide-based Mcl-1 inhibitors into cancer cells. Bioconjug Chem (2014) 0.81
The role of chemokines in hepatitis C virus-mediated liver disease. Int J Mol Sci (2014) 0.81
Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model. Dis Model Mech (2016) 0.81
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease. PLoS One (2014) 0.80
CXCR4: a virus's best friend? Infect Genet Evol (2014) 0.80
Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle (2014) 0.79
Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.78
New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. Int J Mol Sci (2016) 0.78
Chemokines and their receptors in lung cancer progression and metastasis. J Zhejiang Univ Sci B (2016) 0.78
Pharmacological targeting of chemokine (C-X-C motif) receptor 4 in porcine polytrauma and hemorrhage models. J Trauma Acute Care Surg (2016) 0.77
New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. Biochem Pharmacol (2016) 0.77
BRE facilitates skeletal muscle regeneration by promoting satellite cell motility and differentiation. Biol Open (2016) 0.77
Administration of AMD3100 in endotoxemia is associated with pro-inflammatory, pro-oxidative, and pro-apoptotic effects in vivo. J Biomed Sci (2016) 0.76
Ubiquitin and stromal cell-derived factor-1α in bronchoalveolar lavage fluid after burn and inhalation injury. J Burn Care Res (2012) 0.76
Homing in hematopoietic stem cells: focus on regulatory role of CXCR7 on SDF1a/CXCR4 axis. EXCLI J (2016) 0.76
ISG15 regulates IFN-γ immunity in human mycobacterial disease. Cell Res (2012) 0.76
Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE. J Biol Chem (2016) 0.76
Ubiquitin Urine Levels in Burn Patients. J Burn Care Res (2015) 0.75
Ubiquitin is a versatile scaffold protein for the generation of molecules with de novo binding and advantageous drug-like properties. FEBS Open Bio (2015) 0.75
Fatal hemolytic uremic syndrome associated with day care surgery and anaesthesia: a case report. BMC Res Notes (2013) 0.75
Early transcriptional responses of internalization defective Brucella abortus mutants in professional phagocytes, RAW 264.7. BMC Genomics (2013) 0.75
Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro. PLoS One (2016) 0.75
Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach. Mol Clin Oncol (2017) 0.75
Advantages of Extracellular Ubiquitin in Modulation of Immune Responses. Mediators Inflamm (2016) 0.75
α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. J Am Heart Assoc (2017) 0.75
Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists. Mol Cell Biochem (2017) 0.75
Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischemia-reperfusion injury. Clin Exp Pharmacol Physiol (2017) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem (2005) 5.45
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med (2007) 5.28
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood (2005) 5.21
Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res (2008) 3.54
Regulation of CXCR4 signaling. Biochim Biophys Acta (2006) 3.16
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci U S A (1975) 2.77
Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol (1998) 2.66
G-protein signaling: back to the future. Cell Mol Life Sci (2005) 2.38
Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation (2007) 2.35
CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol (1997) 2.35
Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem (2007) 1.98
Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J Immunol (1998) 1.67
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem (2002) 1.59
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol (2006) 1.58
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor. J Biol Chem (2003) 1.50
Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett (2006) 1.46
CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med (2008) 1.35
Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J Pharmacol Exp Ther (2007) 1.34
Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J Biol Chem (2006) 1.32
Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant. J Immunol (1999) 1.23
N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem (1998) 1.22
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett (1995) 1.20
SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis (2008) 1.16
The N- and C-terminal fragments of ubiquitin are important for the antimicrobial activities. FASEB J (2003) 1.14
Ubiquitin enhances the Th2 cytokine response and attenuates ischemia-reperfusion injury in the lung. Crit Care Med (2008) 1.12
Therapeutic potential of exogenous ubiquitin during resuscitation from severe trauma. J Trauma (2004) 1.10
SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study. PLoS One (2008) 1.08
Extracellular ubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3beta and mitochondrial pathways. Cardiovasc Res (2009) 1.07
Effects of exogenous ubiquitin in lethal endotoxemia. Surgery (2004) 1.06
Induction of human granulocyte differentiation in vitro by ubiquitin and thymopoietin. Blood (1977) 1.02
Ubiquitin reduces contusion volume after controlled cortical impact injury in rats. J Neurotrauma (2007) 1.01
Ubiquitin reduces fluid shifts after traumatic brain injury. Surgery (2005) 1.01
Ischemia-related changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage. Exp Neurol (2009) 1.00
Prolongation of skin graft survival by exogenous ubiquitin. Transplantation (2006) 0.93
Ubiquitin immunoreactivity in cerebrospinal fluid after traumatic brain injury: clinical and experimental findings. Crit Care Med (2005) 0.92
Systemic ubiquitin release after blunt trauma and burns: association with injury severity, posttraumatic complications, and survival. J Trauma (2008) 0.91
Targeting the monocytic ubiquitin system with extracellular ubiquitin. Immunol Cell Biol (2005) 0.90
Serum concentrations of free ubiquitin and multiubiquitin chains. Clin Chem (1997) 0.88
Relation between serum ubiquitin levels and KT/V in chronic hemodialysis patients. Nephron (2001) 0.86
Serum ubiquitin levels in patients with alcoholic liver disease. Alcohol Clin Exp Res (1999) 0.85
Effect of ubiquitin on platelet functions: possible identity with platelet activity suppressive lymphokine (PASL). Eur J Immunol (1991) 0.85
The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states. Eur J Pharmacol (2000) 0.84
The immunosuppressive activity and solution structures of ubiquitin fragments. Biopolymers (2009) 0.84
Recombinant human CXC-chemokine receptor-4 in melanophores are linked to Gi protein: seven transmembrane coreceptors for human immunodeficiency virus entry into cells. Mol Pharmacol (1998) 0.84
A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases. J Immunol Methods (1994) 0.84
Ubiquitin-mediated processes in erythroid cell maturation. Adv Exp Med Biol (1991) 0.81
Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res (2008) 2.19
Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem (2007) 1.98
The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol (2003) 1.97
Systemic release of cytokines and heat shock proteins in porcine models of polytrauma and hemorrhage*. Crit Care Med (2012) 1.51
Effects of exogenous ubiquitin in a polytrauma model with blunt chest trauma. Crit Care Med (2012) 1.50
Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J Cell Biol (2007) 1.49
Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4. Mol Biol Cell (2010) 1.32
The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction. Mol Biol Cell (2008) 1.25
Ubiquitination regulates proteolytic processing of G protein-coupled receptors after their sorting to lysosomes. J Biol Chem (2009) 1.24
The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. J Biol Chem (2011) 1.23
CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4. EMBO J (2006) 1.20
Ubiquitin enhances the Th2 cytokine response and attenuates ischemia-reperfusion injury in the lung. Crit Care Med (2008) 1.12
Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J Biol Chem (2013) 1.05
Ubiquitin reduces contusion volume after controlled cortical impact injury in rats. J Neurotrauma (2007) 1.01
Ubiquitin reduces fluid shifts after traumatic brain injury. Surgery (2005) 1.01
A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochem Biophys Res Commun (2009) 0.99
Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem (2011) 0.96
Resuscitation with pressors after traumatic brain injury. J Am Coll Surg (2005) 0.96
Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem (2010) 0.94
Prolongation of skin graft survival by exogenous ubiquitin. Transplantation (2006) 0.93
Building a better fluid for emergency resuscitation of traumatic brain injury. J Trauma (2004) 0.92
AP-3 regulates PAR1 ubiquitin-independent MVB/lysosomal sorting via an ALIX-mediated pathway. Mol Biol Cell (2012) 0.89
Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling. J Biol Chem (2012) 0.89
The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intensive Care Med (2002) 0.87
Extracellular ubiquitin increases in packed red blood cell units during storage. J Surg Res (2006) 0.86
Ubiquitin receptor binding and signaling in primary human leukocytes. Commun Integr Biol (2010) 0.86
Immuno-inflammatory tissue reaction to stainless-steel and titanium plates used for internal fixation of long bones. Biomaterials (2003) 0.86
Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification. Biochemistry (2013) 0.86
A new key in breast cancer metastasis. Cancer Cell (2004) 0.86
Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation. Biochem Biophys Res Commun (2010) 0.85
Initial assessment of the role of CXC chemokine receptor 4 after polytrauma. Mol Med (2012) 0.84
Prehospital HBOC-201 after traumatic brain injury and hemorrhagic shock in swine. J Trauma (2006) 0.83
Traumatic unilateral trochlear nerve palsy. J Trauma (2007) 0.82
The interleukin-6 G(-174)C polymorphism and the ex vivo interleukin-6 response to endotoxin in severely injured blunt trauma patients. Eur Cytokine Netw (2002) 0.80
Proteasomes in human bronchoalveolar lavage fluid after burn and inhalation injury. J Burn Care Res (2009) 0.80
Proteasome inhibition prolongs survival during lethal hemorrhagic shock in rats. J Trauma Acute Care Surg (2013) 0.80
Proteasome peptidase activities parallel histomorphological and functional consequences of ischemia-reperfusion injury in the lung. Exp Lung Res (2009) 0.78
Human leukocyte antigen-DR expression in peripheral blood mononuclear cells from healthy donors influenced by the sera of injured patients prone to severe sepsis. Intensive Care Med (2003) 0.78
Pharmacological targeting of chemokine (C-X-C motif) receptor 4 in porcine polytrauma and hemorrhage models. J Trauma Acute Care Surg (2016) 0.77
Activities of nonlysosomal proteolytic systems in skeletal and cardiac muscle during burn-induced hypermetabolism. J Burn Care Res (2014) 0.77
Ubiquitination of GPCRs. Methods Mol Biol (2011) 0.77
Proteasome Inhibition After Burn Injury. J Burn Care Res (2016) 0.77
Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells. J Infect Chemother (2002) 0.77
Cytosolic ubiquitin and ubiquitylation rates in human peripheral blood mononuclear cells during sepsis. Shock (2005) 0.77
Ubiquitin and stromal cell-derived factor-1α in bronchoalveolar lavage fluid after burn and inhalation injury. J Burn Care Res (2012) 0.76
Ubiquitin Urine Levels in Burn Patients. J Burn Care Res (2015) 0.75
Cardiovascular Responsiveness to Vasopressin and α1-Adrenergic Receptor Agonists After Burn Injury. J Burn Care Res (2016) 0.75